DX-3-235 | Interleukin Related interleukin-related.com

Product Name :
DX-3-235

Search keywords :
MT ND1

drugId :
null

Target Vo:
NADH-ubiquinone oxidoreductase chain 1

Target Vo Short Name :
MT-ND1

Moa_Name:
NADH-ubiquinone oxidoreductase chain 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of Michigan

Active Company_Name :
University Of Michigan

Active Indication_Name:
Pancreatic Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TREM2 Antibody
ATP1A1 Antibody
IRAK-1 Antibody: IRAK-1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 77 kDa, targeting to IRAK-1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts